June 18, 2019 | Tuesday | 11AM EST Clarification of non-settled Lenti suspension harvest can be challenging due to high level of impurities in the feed stream, physical characteristics of the vector, limited filter choices, and low recovery. A series of clarification...
June 27, 2019 | Tuesday | 11AM EST Leachables from single use systems have the potential to impact the quality and safety of your drug product. This presentation will help you understand those risks and how to evaluate them, the current options for test methods and...
PHILADELPHIA, PA (June 4, 2019) – WuXi Advanced Therapies (ATU), a Contract Development and Manufacturing (CDMO) organization dedicated to accelerating and transforming development and manufacturing for cell and gene therapies, is pleased to announce that Felix Hsu,...
“Meeting the Challenge of Manufacturing Advanced Therapies: Cell Therapies, Gene-mediated Cell Therapies, and Viral Vectors” PHILADELPHIA, PA (May 31, 2019) – WuXi Advanced Therapies (ATU), a Contract Development and Manufacturing (CDMO) organization...
The world’s largest advanced therapies partnering event. We believe that through strong partnerships and collaboration, anything can be achieved. That’s why Phacilitate Leaders World and the World Stem Cell Summit will once again be co-located, resulting in the...
Defining Viral Clearance Validation Strategies for Continuous Chromatography We understand that Continuous Processing holds potential to enhance Monoclonal Antibody production with higher yields and lower capital costs. With any emerging technology in a regulated...
